Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CLpro and PLpro), spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin-converting enzyme II receptor (ACE2)
- PMID: 33249077
- PMCID: PMC7691142
- DOI: 10.1016/j.ejphar.2020.173759
Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CLpro and PLpro), spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin-converting enzyme II receptor (ACE2)
Abstract
The novel coronavirus outbreak (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represents the actual greatest global public health crisis. The lack of efficacious drugs and vaccines against this viral infection created a challenge for scientific researchers in order to find effective solutions. One of the promising therapeutic approaches is the search for bioactive molecules with few side effects that display antiviral properties in natural sources like medicinal plants and vegetables. Several computational and experimental studies indicated that flavonoids especially flavonols and their derivatives constitute effective viral enzyme inhibitors and possess interesting antiviral activities. In this context, the present study reviews the efficacy of many dietary flavonols as potential antiviral drugs targeting the SARS-CoV-2 enzymes and proteins including Chymotrypsin-Like Protease (3CLpro), Papain Like protease (PLpro), Spike protein (S protein) and RNA-dependent RNA polymerase (RdRp), and also their ability to interact with the angiotensin-converting enzyme II (ACE2) receptor. The relationship between flavonol structures and their SARS-CoV-2 antiviral effects were discussed. On the other hand, the immunomodulatory, the anti-inflammatory and the antiviral effects of secondary metabolites from this class of flavonoids were reported. Also, their bioavailability limitations and toxicity were predicted.
Keywords: 3CL(pro); ACE2; Flavonols; PL(pro); RdRp; SARS-CoV-2.
Copyright © 2020 Elsevier B.V. All rights reserved.
Conflict of interest statement
None.
Figures




Similar articles
-
Identifying Exifone as a Dual-Target Agent Targeting Both SARS-CoV-2 3CL Protease and the ACE2/S-RBD Interaction Among Clinical Polyphenolic Compounds.Int J Mol Sci. 2025 Mar 2;26(5):2243. doi: 10.3390/ijms26052243. Int J Mol Sci. 2025. PMID: 40076865 Free PMC article. Review.
-
Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection.Virus Res. 2020 Dec;290:198169. doi: 10.1016/j.virusres.2020.198169. Epub 2020 Sep 24. Virus Res. 2020. PMID: 32979476 Free PMC article. Review.
-
Potential inhibitors of SARS-CoV-2: recent advances.J Drug Target. 2021 Apr;29(4):349-364. doi: 10.1080/1061186X.2020.1853736. Epub 2020 Dec 3. J Drug Target. 2021. PMID: 33210953 Review.
-
Gold Metallodrugs to Target Coronavirus Proteins: Inhibitory Effects on the Spike-ACE2 Interaction and on PLpro Protease Activity by Auranofin and Gold Organometallics*.Chemistry. 2020 Nov 26;26(66):15140-15144. doi: 10.1002/chem.202004112. Epub 2020 Oct 19. Chemistry. 2020. PMID: 32915473 Free PMC article.
-
Structural insights of key enzymes into therapeutic intervention against SARS-CoV-2.J Struct Biol. 2021 Mar;213(1):107690. doi: 10.1016/j.jsb.2020.107690. Epub 2020 Dec 29. J Struct Biol. 2021. PMID: 33383190 Free PMC article. Review.
Cited by
-
SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models.Front Pharmacol. 2021 Apr 22;12:638334. doi: 10.3389/fphar.2021.638334. eCollection 2021. Front Pharmacol. 2021. PMID: 33967772 Free PMC article. Review.
-
A molecular dynamics simulation study of the ACE2 receptor with screened natural inhibitors to identify novel drug candidate against COVID-19.PeerJ. 2021 Apr 23;9:e11171. doi: 10.7717/peerj.11171. eCollection 2021. PeerJ. 2021. PMID: 33981493 Free PMC article.
-
Neuroprotective Potentials of Flavonoids: Experimental Studies and Mechanisms of Action.Antioxidants (Basel). 2023 Jan 27;12(2):280. doi: 10.3390/antiox12020280. Antioxidants (Basel). 2023. PMID: 36829840 Free PMC article. Review.
-
Multi-target mechanisms against coronaviruses of constituents from Chinese Dagang Tea revealed by experimental and docking studies.J Ethnopharmacol. 2022 Oct 28;297:115528. doi: 10.1016/j.jep.2022.115528. Epub 2022 Jul 12. J Ethnopharmacol. 2022. PMID: 35835344 Free PMC article.
-
Whey-Derived Peptides at the Heart of the COVID-19 Pandemic.Int J Mol Sci. 2021 Oct 28;22(21):11662. doi: 10.3390/ijms222111662. Int J Mol Sci. 2021. PMID: 34769093 Free PMC article.
References
-
- Lagunas Rangel F.A. Neutrophil‐to‐lymphocyte ratio and lymphocyte‐to‐C‐reactive protein ratio in patients with severe coronavirus disease 2019 (COVID‐19): a meta‐analysis. J. Med. Virol. 2020 https://doi: 10.1002/jmv.25819 - PMC - PubMed
-
- Ai T., Yang Z., Hou H., Zhan C., Chen C., Lv W., Xia L. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. 2020;296:E32–E40. https://doi:10.1148/radiol.2020200642 - DOI - PMC - PubMed
-
- Amaretti A., Raimondi S., Leonardi A., Quartieri A., Rossi M. Hydrolysis of the rutinose-conjugates flavonoids rutin and hesperidin by the gut microbiota and bifidobacteria. Nutrients. 2015;7:2788–2800. https://doi: 10.3390/nu7042788 - PMC - PubMed
-
- Annapurna A., Reddy C.S., Akondi R.B., Rao S.R. Cardioprotective actions of two bioflavonoids, quercetin and rutin, in experimental myocardial infarction in both normal and streptozotocin‐induced type I diabetic rats. J. Pharm. Pharmacol. 2009;61:1365–1374. https://doi: 10.1211/jpp/61.10.0014 - PubMed
-
- Antunes-Ricardo M., Gutiérrez-Uribe J.A., López-Pacheco F., Alvarez M.M., Serna-Saldívar S.O. In vivo anti-inflammatory effects of isorhamnetin glycosides isolated from Opuntia ficus-indica (L.) Mill cladodes. Ind. Crop. Prod. 2015;76:803–808. https://doi:10.1016/j.indcrop.2015.05.089 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous